Amanote Research
Register
Sign In
Intratumoral COX-2 Gene Expression Is a Predictive Factor for Colorectal Cancer Response to Fluoropyrimidine-Based Chemotherapy
Clinical Cancer Research
- United States
doi 10.1158/1078-0432.ccr-04-1650
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
May 1, 2005
Authors
K. Uchida
Publisher
American Association for Cancer Research (AACR)
Related search
PML as a Potential Predictive Factor of Oxaliplatin/Fluoropyrimidine-Based First Line Chemotherapy Efficacy in Colorectal Cancer Patients
Journal of Cellular Physiology
Clinical Biochemistry
Cell Biology
Physiology
Relevance of Methylenetetrahydrofolate Reductase Gene Variants C677T and A1298C With Response to Fluoropyrimidine-Based Chemotherapy in Colorectal Cancer: A Systematic Review and Meta-Analysis
Oncotarget
Oncology
Over-Expression of COX-2 mRNA in Colorectal Cancer
BMC Gastroenterology
Medicine
Gastroenterology
Identification of Predictive DNA Methylation Biomarkers for Chemotherapy Response in Colorectal Cancer
Frontiers in Pharmacology
Pharmacology
BRAF Mutant Colorectal Cancer: ErbB2 Expression Levels as Predictive Factor for the Response to Combined BRAF/ErbB Inhibitors
BMC Cancer
Cancer Research
Oncology
Genetics
Cyclin a as a Predictive Factor for Chemotherapy Response in Advanced Head and Neck Cancer
Clinical Cancer Research
Cancer Research
Oncology
Distinct Patterns of Angiogenic Factor Expression as a Predictive Factor of Response to Chemotherapy in Stage IIIA Non-Small-Cell Lung Cancer Patients
Molecular and Clinical Oncology
Cancer Research
Oncology
Is Diabetes a Risk Factor for Colorectal Cancer?
Digestive Diseases and Sciences
Physiology
Gastroenterology
Predictive Value of TLR7 Polymorphism for Cetuximab-Based Chemotherapy in Patients With Metastatic Colorectal Cancer
International Journal of Cancer
Cancer Research
Oncology
